The Level of Agreement Among Medical Oncologists on Adjuvant Chemotherapy Decision for Breast Cancer in Pre and Post-Oncotype DX Settings

Introduction: The Oncotype DX assay plays an important role in the identification of the specific subset of hormone receptor (HR)-positive and node-negative breast cancer (BC) patients, who would benefit the most from adjuvant chemotherapy. The current study aimed at assessing the level of agreement...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkushi, Abdulmohsen, Omair, Ahmad, Masuadi, Emad, Alamri, Ghaida, Abusanad, Atlal, Abdelhafiez, Nafisa, Mohamed, Amin E, Abulkhair, Omalkhair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958828/
https://www.ncbi.nlm.nih.gov/pubmed/33738150
http://dx.doi.org/10.7759/cureus.13298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958828/
https://www.ncbi.nlm.nih.gov/pubmed/33738150
http://dx.doi.org/10.7759/cureus.13298

Ejemplares similares